Nachrichten zur DBV technologies S.A. Aktie

CHAR Technologies Announces $2.5M from the Government of Québec for Saint-Félicien Biocarbon and Green Hydrogen Project

TORONTO, Dec. 18, 2024 (GLOBE NEWSWIRE) -- CHAR Technologies (“CHAR Tech” or the “Company”) (TSXV:YES), a leader in…

DBV Technologies S.A. (DBVT) Q2 2024 Earnings Call Transcript

…

Invixium Acquires Triax Technologies to Expand its Biometric Solutions with AI-based RTLS Offering for Improved Safety and Productivity at Industrial Sites and Critical Infrastructure

TORONTO, July 17, 2024 (GLOBE NEWSWIRE) -- Invixium, a global leader in biometric access control, workforce, and visitor…

Global Food Allergy Treatment Market Size To Worth USD 13.76 Billion By 2033 | CAGR of 9.27%

The Global Food Allergy Treatment Market Size was Valued at USD 5.67 Billion in 2023 and the Worldwide Food Allergy…

DBV Technologies Announces Results of its 2024 Combined General Meeting

Châtillon, France, May 16, 2024…

Sword Group: Important wins with EUROCONTROL & THE EUROPEAN INVESTMENT FUND

Sword Technologies S.A., a Sword Group company,- in collaboration with Twenty8 S.A. has signed two contracts with EUROCONTROL, the European Organisation…

DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document

Montrouge, France, March 8, 2024 …

DBV Technologies S.A. (DBVT) Q4 2023 Earnings Call Transcript

…

DeFi Protocol BlockGuard Secures Equity Partnership with Pixelette Technologies

As a DeFi protocol, BlockGuard aims to revolutionize risk management in the Web3 economy by enhancing accessibility, transparency, and efficiency…

CasinoTrac™ & TransAct® Announce Industry First Floor-wide, Single-Wire Printing Solution

MINNETONKA, Minn., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Table Trac, Inc. (OTCQX: TBTC) announces it has completed a…

Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates

Golden, Colorado & Nashville, Tennessee, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies (OTC: THER), a precision oncology…

UPDATE: Turntide Technologies Named Energy Transition Changemaker by COP28 UAE Presidency

Sunnyvale, CA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Turntide Technologies was honored as an Energy Transition Changemaker in…

Turntide Technologies Named Energy Transition Changemaker by COP28 UAE Presidency

Sunnyvale, CA, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Turntide Technologies was honored as an Energy Transition Changemaker in…

DBV Technologies to Present New Data at ACAAI 2023

Montrouge, France, November 2, 2023…

DBV Technologies S.A. (DBVT) Q3 2023 Earnings Call Transcript

…

DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results

Montrouge, France, October 31, 2023…

DBV Technologies Announces New England Journal of Medicine Publication of Phase 3 EPITOPE Trial Data Evaluating Viaskin™ Peanut in Toddlers

Montrouge, France, May 10, 2023...…

Form 10-Q DBV Technologies S.A. For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

DBV Technologies Reports First Quarter 2023 Financial Results

Montrouge, France, May 4, 2023...…

DBV Technologies Outlines Regulatory Path for Viaskin Peanut in Children 1 – 3 Years After Receiving Pre-BLA Responses from FDA

Montrouge, France, April 19, 2023...…

DBV Technologies Announces First Patient Screened in VITESSE Phase 3 Clinical Trial in Peanut-Allergic Children 4 – 7 Years Old

Montrouge, France, March 7, 2023...…

dpa-AFX ProFeed